SAN RAMON, Calif.—CooperVision announced today that its innovative MiSight 1 day contact lens will launch in the U.S. early next year as part of a CooperVision myopia management initiative. The initiative is scheduled to begin in March. The MiSight lens received Food and Drug Administration (FDA) approval on Friday (Nov. 15), as VMAIL reported, and will be the cornerstone of a comprehensive myopia management approach to be offered by CooperVision, according to the company’s announcement.

Read more